

Novartis, Merck & Allergan Join Those Raising U.S. Drug Prices for 2020

The Cost of Free Pharmaceutical Services
Amgen Wins U.S. Patent Battle on Arthritis Drug Enbrel
White House Preparing Order that Would Cut Drug Prices for Medicare
Drug Makers Met with Trump to Argue against Senate Pricing Bill
Samsung Bioepis Humira Biosimilar Wins FDA Approval
UnitedHealth Boosts Earnings Forecast, Set to Pass Price Discounts to Patients
WHO Drug Pricing Talks May Fail to End Secrecy, Activists Fear
Trump Slams Drugmakers, Vows to Let U.S. States Buy Cheaper Medicines Abroad
- 1
- 2
- 3
- …
- 13
- Next Page »